Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria.
CONCLUSION: Aldosterone antagonist treatment in obese patients with proteinuric nephropathies induces a drastic and sustained reduction in proteinuria but not more than the non-obese group. There was a trend toward slowing progression of renal failure with few adverse events.
PMID: 26519114 [PubMed - as supplied by publisher]
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research
More News: Chronic Kidney Disease | Diabetes | Eating Disorders & Weight Management | Endocrinology | Gynecomastia | Obesity | Proteinuria | Renal Failure | Spironolactone | Study | Urology & Nephrology